These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33319845)

  • 1. Possible proteomic biomarkers for the detection of pancreatic cancer in oral fluids.
    Deutsch O; Haviv Y; Krief G; Keshet N; Westreich R; Stemmer SM; Zaks B; Navat SP; Yanko R; Lahav O; Aframian DJ; Palmon A
    Sci Rep; 2020 Dec; 10(1):21995. PubMed ID: 33319845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Sjögren's syndrome oral fluid biomarker candidates following high-abundance protein depletion.
    Deutsch O; Krief G; Konttinen YT; Zaks B; Wong DT; Aframian DJ; Palmon A
    Rheumatology (Oxford); 2015 May; 54(5):884-90. PubMed ID: 25339641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Panel of Three Biomarkers Identified by iTRAQ for the Early Diagnosis of Pancreatic Cancer.
    Wu X; Zhang ZX; Chen XY; Xu YL; Yin N; Yang J; Zhu DM; Li DC; Zhou J
    Proteomics Clin Appl; 2019 Sep; 13(5):e1800195. PubMed ID: 31025496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
    Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
    J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of human complement factor B as a novel biomarker candidate for pancreatic ductal adenocarcinoma.
    Lee MJ; Na K; Jeong SK; Lim JS; Kim SA; Lee MJ; Song SY; Kim H; Hancock WS; Paik YK
    J Proteome Res; 2014 Nov; 13(11):4878-88. PubMed ID: 25057901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
    Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
    Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection.
    Xiao H; Zhang Y; Kim Y; Kim S; Kim JJ; Kim KM; Yoshizawa J; Fan LY; Cao CX; Wong DT
    Sci Rep; 2016 Feb; 6():22165. PubMed ID: 26911362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.
    Park J; Lee E; Park KJ; Park HD; Kim JW; Woo HI; Lee KH; Lee KT; Lee JK; Park JO; Park YS; Heo JS; Choi SH; Choi DW; Jang KT; Lee SY
    Oncotarget; 2017 Jun; 8(26):42761-42771. PubMed ID: 28514751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of putative pancreatic cancer biomarkers using subcellular proteomics.
    McKinney KQ; Lee YY; Choi HS; Groseclose G; Iannitti DA; Martinie JB; Russo MW; Lundgren DH; Han DK; Bonkovsky HL; Hwang SI
    J Proteomics; 2011 Jan; 74(1):79-88. PubMed ID: 20807598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Validation of Biomarkers That Distinguish Mucinous and Nonmucinous Pancreatic Cysts.
    Park J; Yun HS; Lee KH; Lee KT; Lee JK; Lee SY
    Cancer Res; 2015 Aug; 75(16):3227-35. PubMed ID: 26122842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma proteomic analysis of pancreatic cancer by 2-dimensional gel electrophoresis.
    Deng R; Lu Z; Chen Y; Zhou L; Lu X
    Pancreas; 2007 Apr; 34(3):310-7. PubMed ID: 17414053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic differential display identifies upregulated vinculin as a possible biomarker of pancreatic cancer.
    Wang Y; Kuramitsu Y; Ueno T; Suzuki N; Yoshino S; Iizuka N; Zhang X; Akada J; Oka M; Nakamura K
    Oncol Rep; 2012 Nov; 28(5):1845-50. PubMed ID: 22940724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics.
    Hirata Y; Kobayashi T; Nishiumi S; Yamanaka K; Nakagawa T; Fujigaki S; Iemoto T; Kobayashi M; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Yamada T; Honda K; Azuma T; Yoshida M
    Clin Chim Acta; 2017 May; 468():98-104. PubMed ID: 28215548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer.
    Duan B; Hu X; Fan M; Xiong X; Han L; Wang Z; Tong D; Liu L; Wang X; Li W; Yang J; Huang C
    Proteomics Clin Appl; 2019 Sep; 13(5):e1900048. PubMed ID: 31207145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery.
    Yu KH; Barry CG; Austin D; Busch CM; Sangar V; Rustgi AK; Blair IA
    J Proteome Res; 2009 Mar; 8(3):1565-76. PubMed ID: 19199705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
    Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
    J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
    Xiong Y; Shi C; Zhong F; Liu X; Yang P
    Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry.
    Wang Y; Kuramitsu Y; Yoshino S; Takashima M; Zhang X; Ueno T; Suzuki N; Oka M; Nakamura K
    Oncol Rep; 2011 Jul; 26(1):287-92. PubMed ID: 21519797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
    Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
    Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.